Mono Pharmacare
Mono Pharmacare Performance
Day Range
- Low 48.50
- High 53.95
52 Week Range
- Low 28.10
- High 58.00
- Open Price48.50
- Previous Close48.50
- Volume252000
Start SIP in Mono Pharmacare
Start SIPMono Pharmacare Investment Rating
-
Master Rating:
-
Mono Pharmacare Ltd has an operating revenue of Rs. 65.25 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 14% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 128 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2022 |
|---|---|
| Total Revenue Annual Cr | 37 |
| Operating Expenses Annual Cr | 36 |
| Operating Profit Annual in Cr | 1 |
| Depreciation Cr | 0 |
| Interest Annual Cr | 1 |
| Tax Annual Cr | 0 |
| Net Profit Annual Cr | 0 |
Mono Pharmacare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹47.48
- 50 Day
- ₹43.56
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹47.88
- 50 Day
- ₹45.33
- 100 Day
- ₹
- 200 Day
- ₹
Mono Pharmacare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 54.70 |
| Second Resistance | 57.05 |
| Third Resistance | 60.15 |
| RSI | 64.13 |
| MFI | 63.42 |
| MACD Single Line | 0.57 |
| MACD | 0.74 |
| Support | |
|---|---|
| First Resistance | 49.25 |
| Second Resistance | 46.15 |
| Third Resistance | 43.80 |
Mono Pharmacare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 252,000 | 18,000,360 | 71.43 |
| Week | 166,400 | 11,759,488 | 70.67 |
| 1 Month | 115,238 | 8,685,495 | 75.37 |
| 6 Month | 106,816 | 9,062,269 | 84.84 |
Mono Pharmacare Result Highlights
Mono Pharmacare Synopsis
NSE-Medical-Whlsle Drg/Suppl
Mono Pharmacare belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 36.98 Cr. and Equity Capital is Rs. 4.28 Cr. for the Year ended 31/03/2022. Mono Pharmacare Ltd. is a Public Limited Listed company incorporated on 06/05/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24304GJ2022PLC136193 and registration number is 136193.| Market Cap | 92 |
| Sales | 37 |
| Shares in Float | 0.76 |
| No of funds | |
| Yield |
| Book Value | 5.24 |
| U/D Vol ratio | 1.3 |
| LTDebt / Equity | 35 |
| Alpha | 0.8 |
| Beta | 1.43 |
Mono Pharmacare
| Owner Name | Sep-23 |
|---|---|
| Promoters | 56.72% |
| Individual Investors | 38.13% |
| Others | 5.15% |
Mono Pharmacare Management
| Name | Designation |
|---|---|
| Mr. Panilam Lakhatariya | Chairman & Managing Director |
| Mrs. Supal Lakhatariya | Non Executive Director |
| Mr. Archit Shah | Executive Director |
| Mr. Mitul Sapara | Non Executive Director |
| Mr. Chinta Trivedi | Ind. Non-Executive Director |
| Mr. Gaurang Vora | Ind. Non-Executive Director |
Mono Pharmacare Forecast
Price Estimates
Mono Pharmacare FAQs
What is Share Price of Mono Pharmacare ?
Mono Pharmacare share price is ₹52 As on 09 December, 2023 | 03:38
What is the Market Cap of Mono Pharmacare ?
The Market Cap of Mono Pharmacare is ₹92.5 Cr As on 09 December, 2023 | 03:38
What is the P/E ratio of Mono Pharmacare ?
The P/E ratio of Mono Pharmacare is As on 09 December, 2023 | 03:38
What is the PB ratio of Mono Pharmacare ?
The PB ratio of Mono Pharmacare is 21.6 As on 09 December, 2023 | 03:38